FNBT
PTCT icon

FineMark National Bank & Trust’s PTC Therapeutics PTCT Stock Holding History

FineMark National Bank & Trust’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13
Closed -$1K – 1444
2014
Q4 		$1K Buy
+13
New +$572 ﹤0.01% 1358

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

FineMark National Bank & Trust's PTCT Position: Q1 2015 in Review

FineMark National Bank & Trust sold out of PTC Therapeutics (PTCT) in Q1 2015, closing a stake of 13 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in PTCT in Q4 2014 and held it in 1 quarter. The position peaked at $1K in Q4 2014. 157 funds tracked by Wall St. Rank hold PTCT as of Q1 2015.

  • FineMark National Bank & Trust reported no remaining PTC Therapeutics position as of Q1 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 13 PTC Therapeutics shares in Q1 2015, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in PTC Therapeutics in Q4 2014 and held it in 1 quarter.
  • FineMark National Bank & Trust's PTC Therapeutics position peaked at $1K in Q4 2014.
  • 157 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2015.

Based on FineMark National Bank & Trust's 13F filing for Q1 2015, filed 13 May 2015.